PE20081878A1 - Compuestos derivados de 1-(4-hidroxifenil sustituido)-4-ol-indazol - Google Patents
Compuestos derivados de 1-(4-hidroxifenil sustituido)-4-ol-indazolInfo
- Publication number
- PE20081878A1 PE20081878A1 PE2008000434A PE2008000434A PE20081878A1 PE 20081878 A1 PE20081878 A1 PE 20081878A1 PE 2008000434 A PE2008000434 A PE 2008000434A PE 2008000434 A PE2008000434 A PE 2008000434A PE 20081878 A1 PE20081878 A1 PE 20081878A1
- Authority
- PE
- Peru
- Prior art keywords
- indazole
- hydroxyphenil
- substituted
- compounds derived
- hydroxyphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE Ra, Rb Y Rc SON CADA UNO HALO, ALCOXI C1-C4, ALQUILO C1-C4, CF3, CN, ENTRE OTROS; m ES 0-3; n ES 0-1; p ES 0-4. SON COMPUESTOS PREFERIDOS: 1-(3-FLUORO-4-HIDROXIFENIL)-1H-INDAZOL-4-OL; 1-(3-FLUORO-4HIDROXIFENIL)-6-METI-1H-INDAZOL-4-OL; 1-(3,5-DIFLUORO-4-HIDROXIFENIL)-4-HIDROXI-1H-INDAZOL-6-CARBONITRILO; ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SE UNENAL RECEPTOR ERBETHA UTILES EN EL TRATAMIENTO DE DOLOR, ENFERMEDADES AUTOINMUNES, TRASTORNOS METABOLICOS O TRASTORNOS DEL APETITO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0704407.6A GB0704407D0 (en) | 2007-03-07 | 2007-03-07 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20081878A1 true PE20081878A1 (es) | 2009-03-05 |
Family
ID=37988543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008000434A PE20081878A1 (es) | 2007-03-07 | 2008-03-05 | Compuestos derivados de 1-(4-hidroxifenil sustituido)-4-ol-indazol |
Country Status (16)
Country | Link |
---|---|
US (1) | US7960563B2 (es) |
EP (1) | EP2118068A1 (es) |
JP (1) | JP2010520259A (es) |
KR (1) | KR20090118998A (es) |
CN (1) | CN101679288A (es) |
AR (1) | AR065605A1 (es) |
AU (1) | AU2008223850A1 (es) |
BR (1) | BRPI0808464A2 (es) |
CA (1) | CA2680109A1 (es) |
CL (1) | CL2008000647A1 (es) |
EA (1) | EA200970835A1 (es) |
GB (1) | GB0704407D0 (es) |
MX (1) | MX2009009581A (es) |
PE (1) | PE20081878A1 (es) |
TW (1) | TW200848025A (es) |
WO (1) | WO2008107455A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途 |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
TWI445532B (zh) | 2007-09-14 | 2014-07-21 | Janssen Pharmaceuticals Inc | 1’,3’-二取代-4-苯基-3,4,5,6-四氫-2h,1’h-〔1,4’〕聯吡啶基-2’-酮化物 |
TW200922566A (en) | 2007-09-14 | 2009-06-01 | Ortho Mcneil Janssen Pharm | 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones |
JP5433579B2 (ja) | 2007-09-14 | 2014-03-05 | ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 1,3−二置換−4−フェニル−1h−ピリジン−2−オン |
ES2637794T3 (es) | 2007-11-14 | 2017-10-17 | Janssen Pharmaceuticals, Inc. | Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2 |
GB0803017D0 (en) | 2008-02-19 | 2008-03-26 | Glaxo Group Ltd | Compounds |
CA2735764C (en) | 2008-09-02 | 2016-06-14 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
ES2466341T3 (es) | 2008-10-16 | 2014-06-10 | Janssen Pharmaceuticals, Inc. | Derivados de indol y benzomorfolina como moduladores de receptores de glutamato metabotrópicos |
WO2010060589A1 (en) | 2008-11-28 | 2010-06-03 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
SG176018A1 (en) | 2009-05-12 | 2011-12-29 | Janssen Pharmaceuticals Inc | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
MX2011011964A (es) | 2009-05-12 | 2012-02-23 | Janssen Pharmaceuticals Inc | Derivados de 1,2,3-triazolo[4,3-a]piridina y su uso para el tratamiento o prevencion de trastornos neurologicos y psiquiatricos. |
GB2483736B (en) | 2010-09-16 | 2012-08-29 | Aragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
PL2649069T3 (pl) | 2010-11-08 | 2016-01-29 | Janssen Pharmaceuticals Inc | Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2 |
ES2536433T3 (es) | 2010-11-08 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
JP5852666B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
US9499538B2 (en) | 2012-03-20 | 2016-11-22 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
UA127921C2 (uk) | 2014-01-21 | 2024-02-14 | Янссен Фармацевтика Нв | Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування |
DK3096790T3 (da) | 2014-01-21 | 2019-10-07 | Janssen Pharmaceutica Nv | Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse |
US11673866B2 (en) | 2018-05-23 | 2023-06-13 | The Board Of Trustees Of The University Of Illinois | Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases |
CN110483403A (zh) * | 2019-09-02 | 2019-11-22 | 南通大学 | 一种5-溴-4-甲氧基-1h-吲唑的合成方法 |
CA3163338A1 (en) * | 2019-12-04 | 2021-06-10 | Arcus Biosciences, Inc. | Inhibitors of hif-2alpha |
JP7474861B2 (ja) | 2020-03-19 | 2024-04-25 | アーカス バイオサイエンシーズ,インコーポレーテッド | Hif-2アルファの阻害剤としてのテトラリン化合物及びテトラヒドロキノリン化合物 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07508259A (ja) * | 1992-03-09 | 1995-09-14 | ゼネカ リミテッド | 新規なアリールインダゾールおよび除草剤としてのその使用 |
DE4236105A1 (de) | 1992-10-26 | 1994-04-28 | Hoechst Ag | Arylboronsäuren als Vorprodukte zur Herstellung von Komponenten von Flüssigkristallmischungen |
US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
JPH0770078A (ja) * | 1993-07-08 | 1995-03-14 | Fuji Photo Film Co Ltd | インダゾールの製造方法 |
US5466823A (en) | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
EP0809636B1 (en) | 1995-02-13 | 2002-09-04 | G.D. Searle & Co. | Substituted isoxazoles for the treatment of inflammation |
ATE183516T1 (de) | 1995-09-08 | 1999-09-15 | Karobio Ab | Waisen-rezeptor |
UA57002C2 (uk) | 1995-10-13 | 2003-06-16 | Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. | Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування |
ES2311571T3 (es) | 1996-04-12 | 2009-02-16 | G.D. Searle Llc | Derivados de bencenosulfonamida sustituidos como profarmacos de inhibidores de cox-2. |
CA2260016C (en) | 1996-07-18 | 2004-03-09 | Merck Frosst Canada Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
CO4960662A1 (es) | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
YU11900A (sh) | 1997-09-05 | 2002-11-15 | Glaxo Group Limited | Derivati 2,3-diaril-pirazolo (1,5-b) piridazina, njihovo dobijanje i njihova upotreba kao inhibitora ciklooksigenaze 2(cox-2) |
US6407261B1 (en) * | 1998-04-17 | 2002-06-18 | Eli Lilly And Company | Process for preparing 4-hdyroxy indole, indazole and carbazole compounds |
CA2349567A1 (en) | 1998-11-03 | 2000-05-11 | Glaxo Group Limited | Pyrazolopyridine derivatives as selective cox-2 inhibitors |
US6025683A (en) | 1998-12-23 | 2000-02-15 | Stryker Corporation | Motor control circuit for regulating a D.C. motor |
US6498166B1 (en) | 1999-02-27 | 2002-12-24 | Smithkline Beecham Corporation | Pyrazolopyridines |
GB0003224D0 (en) | 2000-02-11 | 2000-04-05 | Glaxo Group Ltd | Chemical compounds |
GB0021494D0 (en) | 2000-09-01 | 2000-10-18 | Glaxo Group Ltd | Chemical comkpounds |
EP1403255A4 (en) * | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
KR101160698B1 (ko) * | 2003-06-27 | 2012-06-28 | 아사히 가세이 가부시키가이샤 | 세포 분화 억제제, 이것을 이용하는 세포 배양 방법, 배양 배지 및 배양된 세포주 |
EP1647549A1 (en) | 2004-10-14 | 2006-04-19 | Laboratoire Theramex | Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents |
TW200815361A (en) | 2005-10-20 | 2008-04-01 | Astrazeneca Ab | Chemical compounds |
-
2007
- 2007-03-07 GB GBGB0704407.6A patent/GB0704407D0/en not_active Ceased
-
2008
- 2008-03-04 CL CL2008000647A patent/CL2008000647A1/es unknown
- 2008-03-05 AR ARP080100911A patent/AR065605A1/es unknown
- 2008-03-05 US US12/529,561 patent/US7960563B2/en not_active Expired - Fee Related
- 2008-03-05 PE PE2008000434A patent/PE20081878A1/es not_active Application Discontinuation
- 2008-03-05 BR BRPI0808464-5A patent/BRPI0808464A2/pt not_active IP Right Cessation
- 2008-03-05 EA EA200970835A patent/EA200970835A1/ru unknown
- 2008-03-05 CA CA002680109A patent/CA2680109A1/en not_active Abandoned
- 2008-03-05 EP EP08717414A patent/EP2118068A1/en not_active Withdrawn
- 2008-03-05 KR KR1020097020816A patent/KR20090118998A/ko not_active Application Discontinuation
- 2008-03-05 CN CN200880015045A patent/CN101679288A/zh active Pending
- 2008-03-05 MX MX2009009581A patent/MX2009009581A/es unknown
- 2008-03-05 WO PCT/EP2008/052664 patent/WO2008107455A1/en active Application Filing
- 2008-03-05 JP JP2009552198A patent/JP2010520259A/ja not_active Withdrawn
- 2008-03-05 AU AU2008223850A patent/AU2008223850A1/en not_active Abandoned
- 2008-03-05 TW TW097107583A patent/TW200848025A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20090118998A (ko) | 2009-11-18 |
GB0704407D0 (en) | 2007-04-18 |
AU2008223850A1 (en) | 2008-09-12 |
US20100087502A1 (en) | 2010-04-08 |
BRPI0808464A2 (pt) | 2014-07-15 |
CN101679288A (zh) | 2010-03-24 |
CA2680109A1 (en) | 2008-09-12 |
TW200848025A (en) | 2008-12-16 |
EP2118068A1 (en) | 2009-11-18 |
AR065605A1 (es) | 2009-06-17 |
EA200970835A1 (ru) | 2010-04-30 |
CL2008000647A1 (es) | 2009-01-02 |
JP2010520259A (ja) | 2010-06-10 |
MX2009009581A (es) | 2009-09-16 |
WO2008107455A1 (en) | 2008-09-12 |
US7960563B2 (en) | 2011-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20081878A1 (es) | Compuestos derivados de 1-(4-hidroxifenil sustituido)-4-ol-indazol | |
PE20110329A1 (es) | Agonistas del receptor acoplado a la proteina g piperidinilo | |
PE20110237A1 (es) | Derivados de ciclohexilamida como antagonistas del receptor del factor de liberacion de corticotropina (crf-1) | |
EA200870472A1 (ru) | Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1 | |
DK2021337T3 (da) | Inhibitorer af 11-beta-hydroxysteroid-dehydrogenase-1 | |
MX2007008614A (es) | Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r). | |
ATE445609T1 (de) | Substituierte thiophenderivate als glucagonrezeptorantagonisten, herstellung und therapeutische anwendungen | |
EA201100921A1 (ru) | Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ | |
GEP20135983B (en) | 1-benzyl-3-hydroxymethylindazole derivatives and usage therein treatment of diseases based on mcp-1, cx3cr1 and p40 expression | |
PE20050284A1 (es) | Compuestos peptidicos como agonistas del receptor de melanocortina 4 (mc4) | |
BRPI0911035A2 (pt) | ativadores de pirrolidinona glicoquinase | |
AR062886A1 (es) | Compuestos de tiazol pirazolopirimidina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento | |
MX2010005861A (es) | Agonistas novedosos de los receptores de glucocorticoides. | |
RS20080371A (en) | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines | |
DK2021336T3 (da) | 11-beta-hydroxysteroid-dehydrogenase-1-inhibitorer | |
PE20070498A1 (es) | Compuestos derivados de indoles de acilo como antagonistas del receptor de glucagon | |
PE20050249A1 (es) | Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos | |
CY1111733T1 (el) | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri | |
ATE432926T1 (de) | Oxazolderivate als histamin-h3-rezeptor- wirkstoffe, deren herstellung und therapeutische verwendung | |
JP2011500658A5 (es) | ||
ATE459619T1 (de) | Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung | |
PE20051091A1 (es) | N-ciclohexilimidazolinonas sustituidas y procedimientos para su preparacion | |
EA200700027A1 (ru) | Антагонисты рецептора глюкагона, их получение и терапевтическое применение | |
PE20090592A1 (es) | Nuevos derivados de piperazina-amida | |
EA023861B3 (ru) | Производные пирролидин карбоновой кислоты как агонисты сопряженного с g-белком рецептора 43 (gpr43), фармацевтическая композиция и методы их использования при лечении метаболических нарушений |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |